Nivolumab in refractory cerebral relapse of Hodgkin's lymphoma.

Authors :: Lapierre L
Pericart S
Protin C
Borel C
Ysebaert L
Laurent C
Oberic L
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (12), pp. 3063-3065. Date of Electronic Publication: 2021 Jul 13.
Publication Year :: 2021

Subjects :: Brentuximab Vedotin
Humans
Neoplasm Recurrence, Local drug therapy
Nivolumab therapeutic use
Hodgkin Disease diagnosis
Hodgkin Disease drug therapy
Hodgkin Disease pathology
Immunoconjugates

Full Text Access

Tools